Reply to comment
Biosimilar Product from India
April 10, 2008 by Anonymous, 1 year 32 weeks ago
Comment id: 28753
Reply
About us
Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.Recommended
Andrew Sullivan Dan Sullivan Doug Arellanes Emmanuelle Richard Faith Sullivan Fred Bortz Heather Havrilesky Henry Copeland Kate Sullivan Ken Layne lagreenbean.com LAist.com Maggie Sullivan Matt Welch NewYorkology Opinion L.A. Ron Kaye Slashdot Steve Elzer & Family TheNewsroom.org Thor Garcia Tony Pierce Wonkette OlderThanks CNET for naming Science Blog one of your Blog 100!
India has tremendous and growing potential for the biotechnology business and this post shows that. India has a vast pool of highly educated Medicine and IT professionals who, through their skills, diligence and dedication, are achieving this feat.
Many other Indian companies like Ranbaxy and Cipla are now major exporter of pharmaceutical generic medicines to the United States, Europe and Africa.